Our extensive database of Harvard technologies is available for new product development opportunities that will strengthen your strategic portfolio.

SEARCH

Category:

AVAILABLE TECHNOLOGIES - Microbiology/Infectious Diseases

Results: 33
Case # Lead Inventor Title
3133Harrison, Stephen C.A fusion intermediate state of HIV-1 gp41, targeted by broadly neutralizing antibodies, for purposes of vaccination
2997Lory, StephenSmall-molecule inhibitors of Chlamydia cell growth
2965Van Oijen, Antoine M.A Method to Visualize and Characterize Fusion of Single Membrane-Enveloped Viruses with Target Membranes
2937Qin, XuebinApplication of Domain 4 of ILY for treatment and prevention of foreign ; pathogen infection
2911Silver, PamelaProtein Based Therapies using Quantitatively Designed Proteins
2868Schreiber, Stuart L.Novel Urazole Epoxyquinol Inhibitors of Hepatitis C Virus Replication
2858Desrosiers, Ronald C.AIDS vaccine using gamma-2 herpesvirus as a vector to express lentiviral (AIDS virus) genes
2658Mekalanos, John J.Compositions and Methods for the Prevention; or Treatment of Infection by Psuedomonas aeruginosa
2652Goldberg, Alfred L.Novel Candidates for Tuberculosis Therapy
2605Knipe, David M.siRNA treatment for HSV-2 infection
2568Whelan, Sean P.J.Attenuated RNA Viruses for Vacine and Drug Delivery
2560Shaw, Jared T.Targeting FtsZ Activity Using Novel Antibacterials: Screening Assays, Small Molecule Hits, and Synthetic Pathways to Potent Natural Products
2508Kasper, DennisPrevention of Tularemia Using an Enhanced Live Attenuated Vaccine Strain
2419Harn, Donald AlfredA Novel Class of HIV Therapeutics: Monoclonal Antibodies that Neutralize Previously Resistant HIV Primary Isolates
2406Roth, Frederick P.Simultaneous Study of Multiple Genetic Interactions Using Multi-mutant Yeast
2346Edwards, David A.Next Generation Pulmonary Malarial Vaccine
2301Goldberg, Alfred L.Novel Candidates for Tuberculosis Therapy
2196Kramnik, IgorSusceptibility to Tuberculosis 1 (sst1): Novel Target for Diagnosis and Treatment of Mycobacterium tuberculosis
2070Schaak, DianeToxin-Phage Bacteriocide Antibiotic and Uses Thereof
1903Coen, Donald M.A Sensitive Assay to Identify Inhibitors of HSV DNA Polymerase
1776Munger, KarlMethods to Regulate the Duration of Th2 Activation
1740Rubin, Eric JosephHyperactive mutant of the Himar1 mariner transposase
1558Harrison, Stephen C.Vaccine Compositions & Methods for Human Papilloma Virus
1546Knipe, David M.Drug screening tool for herpes antivirals
1475Mekalanos, John J.Systematic, condition-independent identification of essential genes of microorganisms
1416Hogle, James M.Novel Chemistry and Method to make Compounds Active Against Picornaviruses
1173Coen, Donald M.High Lead Expression of Soluble CMV UL97 and Development of an Assay to Screen Inhibitors
1130Telford, Sam R.A Strain of the Ehrlichial Agent
1127Swanson, JoelLiposome- Based, Intracellular Delivery of Drugs into Phagocytes, B- and T- cells and their tumor cells.
1121Munger, KarlMethod and Kit for Evaluating Transformed Cells
0806Essex, Myron EDeglycosylating gp120
0669Desrosiers, Ronald C.Primate Lentivirus Vaccine
0641Neutra, Marian R.Hydroxapatite -Antigen Conjugates & Methods for Generating A Poly-IG Immune Resp